Beryl Capital Management’s Immunomedics Inc IMMU Stock Holding History

Beryl Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,046,632	Closed	-$89M	–	262
2020 Q3	$89M	Buy	+1,046,632	New	+$52.9M	16.02%	1

Beryl Capital Management's IMMU Position: Q4 2020 in Review

Beryl Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,046,632 shares — an estimated $89M sold.

Beryl Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $89M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Beryl Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Beryl Capital Management sold 1,046,632 Immunomedics Inc shares in Q4 2020, an estimated $89M.
Beryl Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Beryl Capital Management's Immunomedics Inc position peaked at $89M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Beryl Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.